Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.410
-0.040 (-2.76%)
Jul 11, 2025, 10:04 AM - Market open
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$57,821
Profits / Employee
-$129,991
Market Cap
12.58M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
EVGN News
- 3 days ago - Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - PRNewsWire
- 4 weeks ago - Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PRNewsWire
- 7 weeks ago - Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Evogene Reports First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Evogene Schedules First Quarter 2025 Financial Results Release - PRNewsWire
- 2 months ago - ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PRNewsWire
- 4 months ago - Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire